Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Tropic Biosciences | 2026 | Series C | $105.0M | London |
| BarkBox | 2026 | Post Ipo Debt | $35.0M | New York |
| Mesodyne | 2026 | Grant | Undisclosed | Somerville |
| TRex Bio | 2026 | Series Unknown | $50.0M | South San Francisco |
| Primmune Therapeutics | 2026 | Series B | $23.3M | San Diego |
| EpiBiologics | 2026 | Series B | $107.0M | San Mateo |
| Muna Therapeutics | 2026 | Grant | $1.0M | Copenhagen |
| Nomad Health | 2025 | Series Unknown | $33.8M | New York |
| Invivyd | 2025 | Post Ipo Equity | $125.0M | Waltham |
| Proof | 2025 | Series Unknown | $15.7M | Boston |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 1 | Tropic Biosciences | Series C | $105.0M | London, United Kingdom |
| 2 | BarkBox | Post Ipo Debt | $35.0M | New York, United States |
| 3 | Mesodyne | Grant | Undisclosed | Somerville, United States |
| 4 | TRex Bio | Series Unknown | $50.0M | South San Francisco, United States |
| 5 | Primmune Therapeutics | Series B | $23.3M | San Diego, United States |
| 6 | EpiBiologics | Series B | $107.0M | San Mateo, United States |
| 7 | Muna Therapeutics | Grant | $1.0M | Copenhagen, Denmark |
| 8 | Nomad Health | Series Unknown | $33.8M | New York, United States |
| 9 | Invivyd | Post Ipo Equity | $125.0M | Waltham, United States |
| 10 | Proof | Series Unknown | $15.7M | Boston, United States |
Tropic Biosciences is a pioneering leader in the development of novel high-performing commercial tropical crop varieties and traits.
Barkbox is a monthly subscription service platform that provides dog products.
Mesodyne manufactures the LightCell: a high energy density, silent, compact power generator converting any fuel to electricity via light.
TRex Bio is a biotechnology company that treats diseases like cancer, fibrotic by studying human tissues.
Primmune Therapeutics is a Biotechnology company.
EpiBiologics develops antibody-based targeted therapies against membrane and extracellular proteins.
Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.
Nomad Health is an online staffing marketplace that connects clinicians to healthcare jobs.
Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.
Proof is an identity-assured transaction management platform that verifies identities and secures digital transactions.
Sovato Health provides surgical access through remote robotic surgeon options.
Indomo is a clinical-stage firm that aims to improve access to quality healthcare through novel device-enabled treatments.
Leyden Labs provides a platform that targets commonalities of viral families to protect humanity from known and future viruses.
Crossbow Therapeutics is a biotech company developing a new type of cancer treatment.
Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers.
Cirrus Therapeutics is a Biotechnology Research firm diganosing and treating eye diseases affecting ocular immune system.
Compass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases.
Auron aims to cure cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells.
Whisker Labs develops cutting-edge sensor technology to protect homes and communities from electrical fires and bad utility power.
Cohere Health is a SaaS company that focuses on improving the efficiency and effectiveness of healthcare delivery.
Tectonic Therapeutic is a biotechnology company which focuses on scientific research in biochemistry and molecular pharmacology.
FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.
Soufflé Therapeutics has potent, precise, and safe medicines can be designed and developed for all diseases.
Falkonry is an Industrial AI software company that provides automated data analysis to the manufacturing and defense industries.
Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel.
Showing 1-0 of 0 portfolio companies
Polaris Partners has invested in 0 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Polaris Partners's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Biopharma. The firm invests across 34 different industry categories.
Among tracked funding rounds, Soufflé Therapeutics received $200.0M in a Series A round. Polaris Partners's total known invested capital is $5.6B.
Polaris Partners's average investment size is $53.2M across its portfolio of 0 companies.
Recent Polaris Partners portfolio additions include Tropic Biosciences, BarkBox, Mesodyne, TRex Bio, Primmune Therapeutics. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors